Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden
· Delayed Price · Currency is SEK 4.635
-0.125 (-2.63%)
At close: Dec 5, 2025
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.83 billion as of December 5, 2025. Its market cap has decreased by -2.14% in one year.
Market Cap
1.83B
Enterprise Value
1.78B
Revenue
55.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.64
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.83B, an increase of 714.43%. That is a compound annual growth rate of 15.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 118.22B |
| Getinge AB | 57.39B |
| Sectra AB | 53.56B |
| Camurus AB | 36.00B |
| Medicover AB | 34.89B |
| Asker Healthcare Group AB | 34.84B |
| BioArctic AB | 28.29B |
| AddLife AB | 22.29B |